Results 141 to 150 of about 76,979 (321)

Epidemiology, Nasopharyngeal Carriage, Serotype Prevalence, and Antibiotic Resistance of Streptococcus pneumoniae in Indonesia

Infectious Diseases and Therapy, 2020
In Indonesia, pneumococcal disease represents a considerable public health concern; however, published data on the epidemiology, nasopharyngeal carriage, serotype prevalence, and antibiotic resistance of Streptococcus pneumoniae in this region are ...
Cissy B. Kartasasmita, Sri Rezeki Hadinegoro, Nia Kurniati, Rina Triasih, Carolina Halim, Amgad Gamil   +5 more
doaj   +1 more source

Rapid replacement by non-vaccine pneumococcal serotypes may mitigate the impact of the pneumococcal conjugate vaccine on nasopharyngeal bacterial ecology

Scientific Reports, 2017
There is growing concern that interventions that alter microbial ecology can adversely affect health. We characterised the impact of the seven-valent pneumococcal conjugate vaccine (PCV7) on pneumococcal carriage and the bacterial component of the ...
B. Kwambana-Adams, B. Hanson, A. Worwui, S. Agbla, Ebenezer Foster-Nyarko, Fatima Ceesay, Chinelo Ebruke, U. Egere, Yanjiao Zhou, Maze Ndukum, E. Sodergren, M. Barer, R. Adegbola, G. Weinstock, M. Antonio   +14 more
semanticscholar   +1 more source

Clinical and bacteriological characteristics of invasive pneumococcal disease after pneumococcal 10-valent conjugate vaccine implementation in Salvador, Brazil

Brazilian Journal of Infectious Diseases, 2016
Invasive pneumococcal disease is a relevant public health problem in Brazil, especially among children and the elderly. In July/2010 a 10-valent pneumococcal conjugate vaccine was introduced to the immunization schedule of Brazilian children under two ...
Carolina Regis Leite, Jailton Azevedo, Vivian Santos Galvão, Otávio Moreno-Carvalho, Joice Neves Reis, Cristiana Nascimento-Carvalho   +5 more
doaj  

Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa

PLoS ONE, 2017
Introduction Streptococcus pneumoniae is a leading cause of severe bacterial infections globally. A full understanding of the impact of pneumococcal conjugate vaccine (PCV) on pneumococcal disease burden, following its introduction in 2009 in South ...
C. von Mollendorf, S. Tempia, A. von Gottberg, S. Meiring, V. Quan, C. Feldman, J. Cloete, S. Madhi, K. O'Brien, K. Klugman, C. Whitney, C. Cohen   +11 more
semanticscholar   +1 more source

Evaluation of differences in S. pneumoniae colonization among children with and without clinically diagnosed asthma/wheeze [PDF]

, 2017
Streptococcus pneumoniae colonization is the nasopharynx is common in young children. Colonization of S. pneumoniae is a necessary precursor for invasive pneumococcal disease (IPD), which is a major cause of morbidity and mortality among children less ...
Alishahi, Musheng
core  

Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children

Journal of Immunology Research, 2015
Applications of the heptavalent pneumococcal conjugate vaccine (PCV7) in the pediatric immunization schedule have dramatically reduced the incidence of pneumococcal diseases in both vaccinated children and unvaccinated individuals of all ages.
Susanna Esposito, Nicola Principi
doaj   +1 more source

IMMUNOGENICITY OF A PNEUMOCOCCAL PROTEIN CONJUGATE VACCINE IN INFANTS WITH SICKLE CELL DISEASE. ▴ 946 [PDF]

, 1996
Katherine L. O’Brien, Jerry A. Winkelstein, Mathuram Santosham, Andrea J. Swift, George J. Dover, Allen E. Eskenazi, Ruth E. Luddy, Archie S. Golden, Joseph E. Gootenberg, Frank Malinoski, Howard M. Lederman   +10 more
openalex   +1 more source

Variation at the capsule locus, cps, of mistyped and non-typable Streptococcus pneumoniae isolates [PDF]

, 2012
The capsule polysaccharide locus (cps) is the site of the capsule biosynthesis gene cluster in encapsulated Streptococcus pneumoniae. A set of pneumococcal samples and non-pneumococcal streptococci from Denmark, the Gambia, the Netherlands, Thailand, the
Antonio, M, Bentley, SD, Bootsma, HJ, Gould, KA, Hanage, WP, Hermans, PW, Hinds, J, Lambertsen, L, O'Brien, KL, Salter, SJ, Turner, P   +10 more
core   +1 more source

EVALUATION OF A PENTAVALENT CONJUGATED PNEUMOCOCCAL VACCINE IN TODDLERS.▴ 1077 [PDF]

, 1996
Michael E. Pichichero, Mark Shelly, John J. Treanor   +2 more
openalex   +1 more source

Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England

PLoS ONE, 2016
Background Recently a large clinical trial showed that the use of 13-valent pneumococcal conjugate vaccine (PCV13) among immunocompetent individuals aged 65 years and over was safe and efficacious.
A. V. van Hoek, E. Miller
semanticscholar   +1 more source